Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 3/20 | 0.56 |
| ▸ | BRD4 | O60885 | 2/20 | 0.45 |
| ▸ | CBFB | Q13951 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PRNP | P04156 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28915576 | 0.98 | PARP1 (0.55) | PARP1BRD4CBFBDRD4DRD3 | |
| SCHEMBL20828600 | 0.83 | BRD4 (0.51) | PARP1BRD4MGAMGAASI | |
| SCHEMBL20878376 | 0.77 | BRD4 (0.56) | PARP1BRD4DRD4DRD3MEN1 | |
| SCHEMBL3171067 | 0.76 | PARP1 (0.52) | PARP1BRD4DRD4DRD3MEN1 | |
| SCHEMBL1261706 | 0.74 | PARP1 (0.55) | PARP1BRD4DRD4DRD3MEN1 | |
| SCHEMBL900151 | 0.74 | MEN1 (0.52) | PARP1BRD4DRD4DRD3MEN1 | |
| SCHEMBL312427 | 0.74 | PARP1 (0.56) | PARP1BRD4DRD4DRD3GAA | |
| SCHEMBL3157571 | 0.74 | PARP1 (0.50) | PARP1BRD4DRD4DRD3MEN1 | |
| SCHEMBL2884811 | 0.74 | PARP1 (0.56) | PARP1BRD4DRD4DRD3MEN1 | |
| SCHEMBL13857864 | 0.74 | PARP1 (0.50) | PARP1BRD4DRD4DRD3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2321 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119563048-A | Passivation coating on copper metal surfaces for copper wire bonding applications | 北德克萨斯大学 | 2025-03-04 | — | — | CN | claimed |
| WO-2024201393-A1 | METHODS FOR THE SYNTHESIS OF NUCLEOSIDE ANALOGUES AND NUCLEOSIDES ANALOGUES DERIVED THEREFROM | SIMON FRASER UNIVERSITY (CA) | 2024-10-03 | — | — | WO | claimed |
| US-20240254546-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | AMPLIWISE INC. (US) | 2024-08-01 | — | — | US | claimed |
| EP-4090768-B1 | COMPOSITIONS, KITS AND METHODS FOR ISOLATING TARGET POLYNUCLEOTIDES | DNAE DIAGNOSTICS LTD (GB) | 2024-03-13 | — | — | EP | claimed |
| CN-111788183-B | Heterocyclic fused phenyl compounds useful for inhibiting TNIK and medical uses thereof | 韩国化学硏究院 | 2024-02-23 | — | — | CN | claimed |
| US-11827925-B2 | Compositions and methods for nucleic acid amplification | AMPLIWISE INC. (US) | 2023-11-28 | — | — | US | claimed |
| CN-117106189-A | Metal organic framework artificial hydrolase and preparation method and application thereof | 华南理工大学 | 2023-11-24 | — | — | CN | claimed |
| EP-3749647-B1 | N-(5-(PHENYL)-1H-PYRAZOL-3-YL)-1H-INDOL-5-AMINE DERIVATIVES AS TNIK INHIBITORS FOR THE TREATMENT OF CANCER | KOREA RES INST CHEMICAL TECH (KR) | 2023-09-27 | — | — | EP | claimed |
| CN-116606685-A | Water-soluble temper rolling liquid composition for non-degreased annealed steel sheet | 大同化学株式会社 | 2023-08-18 | — | — | CN | claimed |
| CN-114457145-B | Linkers, constructs, methods and uses for characterizing target polynucleotide sequencing | 成都齐碳科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| US-20150038554-A1 | Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression | NOVO NORDISK A/S (DK) | 2015-02-05 | — | — | US | claimed |
| US-20130041010-A1 | COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA CONTAINING MODIFIED NUCLEOTIDES | DICERNA PHARMACEUTICALS, INC. (US) | 2013-02-14 | — | — | US | claimed |
| US-20110288147-A1 | Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop | DICERNA PHARMACEUTICALS, INC. | 2011-11-24 | — | — | US | claimed |
| EP-2341943-A2 | COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS | Dicerna Pharmaceuticals, Inc. (US) | 2011-07-13 | — | — | EP | claimed |
| WO-2011033235-A1 | COMPOSITE MATERIAL COMPRISING AN ORGANIC-INORGANIC MATERIAL, PREPARATION PROCESS, AND USES | TREDI (FR) | 2011-03-24 | — | — | WO | claimed |
| US-20100331389-A1 | Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides | DICERNA PHARMACEUTICALS, INC. | 2010-12-30 | — | — | US | claimed |
| WO-2010033225-A2 | COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS | DICERNA PHARMACEUTICALS, INC. (US) | 2010-03-25 | — | — | WO | claimed |
| EP-2091929-A1 | AGENTS THAT DISRUPT CELLULAR REPLICATION AND THEIR USE IN INHIBITING PATHOLOGICAL CONDITIONS | The European Molecular Biology Laboratory (DE) | 2009-08-26 | — | — | EP | claimed |
| CN-101421257-A | Agents that disrupt cellular replication and their use in inhibiting pathological conditions | EUROPEAN MOLECULAR BIOLOGY LAB EMBL (DE) | 2009-04-29 | — | — | CN | claimed |
| WO-2007107352-A1 | AGENTS THAT DISRUPT CELLULAR REPLICATION AND THEIR USE IN INHIBITING PATHOLOGICAL CONDITIONS | THE EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2007-09-27 | — | — | WO | claimed |